Pombiliti Atga 71904-0200
Generic: Cipaglucosidase Alfa-Atga
Product NDC
71904-0200- Manufacturer
- Amicus Therapeutics Us, Llc
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 11, 2023
- Listing Expires
- December 31, 2026
- Application
- BLA761204
Need to source Pombiliti Atga? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Cipaglucosidase Alfa | 105 mg/1 |
Drug Class
Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]alpha-Glucosidases [CS]
Packaging Options(3)
1 VIAL, GLASS in 1 CARTON (71904-200-01) / 105 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS
10 VIAL, GLASS in 1 CARTON (71904-200-02) / 105 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS
25 VIAL, GLASS in 1 CARTON (71904-200-03) / 105 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS